Peridol Tablets 3 mg (Haloperidol)

Adult dose

Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, and Tourette syndrome (Gilles de la Tourette's syndrome): The initial dose of haloperidol is 1-15㎎ per day, administered orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). When a therapeutic response is achieved, gradually reduce the dose to the minimum effective maintenance dose. Dosage may be adjusted as appropriate according to age and symptoms. In elderly or debilitated patients, the initial dose of haloperidol is 1-6mg per day, administered orally in 2-3 divided doses.

Child dose

Age 14 years and older: Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): The initial dose of haloperidol is 1-15㎎ per day, administered orally in 2-3 divided doses (in severe cases, up to 100㎎ may be administered). Once a therapeutic response is achieved, gradually reduce the dose to the minimum effective maintenance dose.

This medication may increase the risk of death when treating psychotic symptoms related to cognitive impairment in elderly dementia patients, so caution is required. Special care should be taken when using this medication in patients at risk of stroke. Additionally, this medication may increase the risk of venous thromboembolism; therefore, it is necessary to assess thrombotic risk factors and take preventive measures before and during administration. It should not be administered to patients with hypersensitivity to this medication, coma, alcohol addiction, severe heart failure, Parkinson's disease, certain types of dementia, and women who are pregnant or breastfeeding. It should also be used cautiously in patients with impaired liver or kidney function, cardiovascular disease, seizure disorders, thyroid dysfunction, children, and the elderly. This medication can cause various side effects, including heart rhythm disturbances, blood pressure changes, muscle rigidity, movement disorders, liver function abnormalities, visual disturbances, allergic reactions, blood abnormalities, gastrointestinal disturbances, respiratory issues, and neuropsychiatric symptoms, and if any unusual symptoms occur, medical personnel should be notified immediately. This medication may interact with other central nervous system depressants, certain cardiac medications, antidepressants, and antibiotics, so it is essential to inform about any co-administered medications. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication and must discontinue breastfeeding during the course of treatment. Care should be taken when administering this medication to children or the elderly as movement disorders may occur easily. In cases of overdose, severe movement disorders, lowered blood pressure, and coma may occur, necessitating immediate emergency care. During the course of taking this medication, patients should avoid dangerous activities such as driving or operating machinery and should not abruptly stop taking the medication but rather taper the dosage as directed by a physician.

increased mortality, increased risk of cerebrovascular diseases, venous thromboembolism, electrocardiogram abnormalities, hypotension, hypertension, tachycardia, ventricular tachycardia, thromboembolism, motor paralysis, muscle rigidity, dysphagia, fever, increased white blood cell count, elevated serum CPK, myoglobinuria, impaired kidney function, high fever, altered consciousness, dyspnea, circulatory collapse, dehydration symptoms, acute renal failure, acute dystonia, torticollis, trismus, parkinsonism, tremor, inability to move, inability to sit still, irreversible involuntary hypertonic movement disorder syndrome, hepatitis, jaundice, liver dysfunction, retinitis, cataracts, ocular accommodation disorder, blurred vision, corneal opacification, corneal pigmentation, edema, erythema, urticaria, exfoliative dermatitis, photosensitivity, anaphylactic reaction, anemia, leukocytosis, leukopenia, erythrocytopenia, agranulocytosis, loss of appetite, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, gynecomastia, galactorrhea, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypotonic hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, bronchospasm, laryngospasm, dyspnea, insomnia, anxiety, drowsiness, dizziness, headache, anxiety, depression, hallucinations, agitation, thirst, nasal congestion, fatigue, urinary retention, fever, sweating, flushing, hypothermia

This medication should be stored in a tightly sealed container that can block light and at a temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a long time.

Appearance

Yellow round tablets

Package unit

1000 tablets/bottle